Section 7 AAC 27.560 - Confirmation(a) Diagnostic testing must be conducted on a newborn child with abnormal screening test results when required by the designated laboratory. A health care provider who ordered a screening test under 7 AAC 27.530 shall arrange for a newborn child with an abnormal result to have that diagnostic testing performed.(b) A specimen must be obtained for the diagnostic testing upon request by the department. The department will pay for one or more of the following diagnostic tests required under (a) of this section if the testing is done by a laboratory designated by the department: (2) plasma acylcarnitines;(4) total and free carnitine; (5) total plasma homocysteine;(8) urine succinylacetone. (c) The health care provider who ordered the screening test in 7 AAC 27.530 may choose to use a diagnostic laboratory other than the designated laboratory for a diagnostic test required under (a) of this section of the specimen. However, the department will not pay for costs incurred by use of a nondesignated laboratory for the testing.(d) If diagnostic confirmatory testing is done through a nondesignated laboratory, the health care provider shall report, in writing, the results of the diagnostic testing to the newborn bloodspot screening program in the department, not later than two days after the date of receipt of results of the diagnostic testing.(e) When a newborn child has an abnormal screening test result and a diagnostic report is not received by the department from the health care provider, the department will contact the child's health care provider.(f) The department will provide the child's health care provider with a consultation with an appropriate medical specialist for a newborn child undergoing diagnostic testing due to abnormal screening results. Eff. 12/30/77, Register 64; am 2/3/88, Register 105; am 7/13/94, Register 131; am 7/16/2011, Register 199; am 7/1/2018,Register 226, July 2018The address for the newborn bloodspot screening (NBS) program in the department is the Department of Health and Social Services, division of public health, section of women's, children's, and family health, 3601 C Street, Suite 322, Anchorage, Alaska 99503.
Authority:AS 18.05.040
AS 18.15.200